Global Real-World Evidence Shows Survival Benefit of Maintenance Therapy Post-Autologous Stem Cell Transplant in Multiple Myeloma

Highlight

1. Maintenance therapy after autologous hematopoietic cell transplantation (AHCT) significantly improves 3-year overall survival in newly diagnosed multiple myeloma (NDMM) patients compared to no maintenance.